Concepedia

John Albanese

JA

4

Publications

175

Citations

4

H-Index

2010

Active since

Affiliations

Bayer (United States)(Current)

McMaster University

Feinstein Institute for Medical Research

Northwell Health

Thrombosis and Atherosclerosis Research Institute

John Albanese is an author at Bayer (United States) specializing in patient safety, pulmonary embolism, and clinical trials.

Top concepts

Publications per year

2010–2022

4

Publications

4

Comparative glycemic control, safety and patient ratings for a new 4 mm <b>×</b> 32G insulin pen needle in adults with diabetes

Laurence Hirsch, Michael A. Gibney, John Albanese et al. · Current Medical Research and Opinion · 2010 · 104 citations

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

Gary E. Raskob, Alex C. Spyropoulos, Alexander T. Cohen et al. · Journal of the American Heart Association · 2021 · 42 citations · Full text

Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials

Jeffrey I. Weitz, Gary E. Raskob, Alex C. Spyropoulos et al. · Thrombosis and Haemostasis · 2020 · 19 citations · Full text

Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness

Gary E. Raskob, Walter Ageno, Gregory W. Albers et al. · Journal of the American Heart Association · 2022 · 10 citations · Full text

, , +18

Rows per page

1–4 of 4